Schubert & CO Catalent, Inc. Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$45.44 - $74.26 $727 - $1,188	16 Added 84.21%	35 $2,000
Q4 2022 Jan 31, 2023	BUY	$41.39 - $81.0 $579 - $1,134	14 Added 280.0%	19 $0
Q3 2022 Oct 21, 2022	SELL	$72.36 - $113.1 $1,881 - $2,940	-26 Reduced 83.87%	5 $0
Q2 2022 Aug 01, 2022	BUY	$87.2 - $114.05 $1,482 - $1,938	17 Added 121.43%	31 $3,000
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $188 - $248	2 Added 16.67%	14 $2,000
Q4 2021 Jan 28, 2022	BUY	$119.57 - $139.07 $1,434 - $1,668	12 New	12 $2,000

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.